Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

136 results about "Tissue engineered skin" patented technology

The tissue-engineered skin used (Apligraf) is a bilayered human skin equivalent developed from foreskin. It is the only Food and Drug Administration–approved skin equivalent of its kind. It is approved for the treatment of venous ulcers of the lower extremities.

Preparation method of tissue engineering skin containing hair follicles

InactiveCN101775366APerfect development conditionsOvercoming small quantitiesEpidermal cells/skin cellsPharmaceutical delivery mechanismEpitheliumCuticle
The invention relates to a preparation method of tissue engineering skin containing hair follicles. In the invention, tissue engineering hair follicles are evenly inoculated in a tissue engineering dermal layer formed by compounding a bracket material and cells, then the tissue engineering dermal layer is covered by epidermal cells, and the tissue engineering skin containing the hair follicles is formed after culture; the invention overcomes the defects of little number of the hair follicles in the skin, no uniformity and uncontrollable quantity of the hair follicles caused by mixed injection formerly, and the prepared tissue engineering skin contains an epidermis, dermis and hair follicle type tissue structure, wherein the number of the hair follicles approaches to the natural number, the hair follicles are evenly distributed in artificial pores and develop continuously after in-vitro culture and transplantation, a multi-layer concentric circle structure is formed, an inner layer is hair papilla cells wrapt by micro-capsule membranes, and an outer layer is epithelium class cells; and the skin cultured in vitro or transplanted in vivo finally forms functional skin containing a hair follicle accessory structure, and the regeneration of the hair follicles after skin transplantation can be realized.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY +1

Double-layer collagen-chitosan sponges bracket and method of preparing the same

InactiveCN101254313AImprove biological characteristicsIncrease the number of stopsProsthesisCross-linkAcetic acid
The invention discloses a dual-layer collagen-chitosan sponge scaffold and a preparation method thereof, and relates to a tissue engineering scaffold. The invention provides the dual-layer collagen-chitosan sponge scaffold for the tissue engineering skin and the preparation method thereof. The scaffold is a dual-layer mesh structure, the upper and the lower layers are collagen and chitosan composite films, and the hole diameters of the layered and hole-shaped structure are mutually penetrated. The collagen hydration solution is dissolved in acetic acid for preparing the collagen dispersion solution with the concentration of 0.2 percent to 0.5 percent and 0.5 percent to 0.8 percent; the chitosan is dissolved in the acetic acid for preparing the chitosan dispersion solution with the concentration of 0.2 percent to 0.5 percent and 0.5 percent to 0.8 percent; the two dispersion solutions are mixed to obtain two collagen-chitosan solutions; the collagen-chitosan solution with the concentration of 0.5 percent to 0.8 percent is frozen overnight, the sponge-like white scaffold is obtained by drying, and the single-layer scaffold is obtained by cross-linking after the film pressing, cleaning, freezing overnight and drying; the collagen-chitosan solution is poured in for freezing overnight and drying to obtain the dual-layer scaffold, and the cross-linking, the cleaning, the freezing overnight, the freezing and the drying are carried out.
Owner:XIAMEN UNIV

Tissue engineered skin with basilar membrane and construction method thereof

The invention relates to the technical fields of tissue engineering and medical wound repair. At present, a living skin substitute constructed by using the materials of polylactic acid, polyglycolic acid, collagen, hyaluronic acid, and the like as a dermic bracket has the defects that on one hand, host materials are difficult to extract, the living skin substitute has complicated manufacturing technology and is expensive in cost and difficult to widely popularize and apply clinically; and on the other hand, the living skin substitute does not have a skin basilar membrane structure so that healed skin does not resist pressure and wear, and the living skin has unfirm adhesion to the epidermis and is easy to shed and break or form water blisters so that the structural and morphological development of the normal epidermis is influenced; and allogeneic acellular dermis is taken from cadaver skin and is limited in sources and expensive in cost, and thus clinical application is limited. The invention aims at providing a skin substitute which uses surface-finished and modified amnion as the basilar membrane and blood plasma as stroma, which has the advantages of wide material sources, low cost and simple preparation method. An animal experiment proves that the complete basilar membrane and hemidesmosomes can be retained in in-vivo transplantation, and the formation of an epidermal structural form is accelerated and promoted.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

In-vitro inducing differentiation of umbilical cord mesenchymal stem cells into tissue engineering skin seed cells

The invention relates to in-vitro inducing differentiation of umbilical cord mesenchymal stem cells into skin tissue engineering seed cells. The invention discloses a new research direction for human umbilical cord mesenchymal stem cells, i.e. in-vitro inducting differentiation into skin tissue engineering seed cells. The invention also discloses an experimental method thereof, which comprises the following steps: collecting the caesarean umbilical cords in aseptic environment; culturing original-generation umbilical cord mesenchymal stem cells (UCMSCs) by an enzyme digestion or tissue-piece adherent method; after purifying and subculturing to the third generation, inducing by using different in-vitro condition induction liquids to differentiate into epidermis stem cells and fibroblasts; and inducing and differentiating epidermis stem cells and fibroblasts into sudoriferous gland cells by using coculture mode with the normal sudoriferous cells. After the induced cells are digested, liquid nitrogen is stored for later use. The invention provides seed cells for skin tissue engineering, and has the advantages of strong multiplication capacity, easy inducing differentiation, low immunogenicity, abundant sources and easy obtainment.
Owner:FIRST HOSPITAL AFFILIATED TO GENERAL HOSPITAL OF PLA

Preparation method of tissue engineering skin containing appendant organs

The invention relates to a preparation method of tissue engineering skin containing appendant organs. In the invention, the preparation method comprises the following steps of: inoculating amniotic mesenchyme stem cells, amniotic mesenchyme stem cells induced to the directions of hair papillae, amniotic epithelial cells and amniotic epithelial cells induced to the directions of the epithelia of the sweat gland into a gel solution, then inoculating the amniotic epithelial cells and the amniotic epithelial cells induced by keratinocyte in a warp direction on the surface of a structure of the hair follicle and the sweat gland after culturing by a dermal layer by induced culture forming the structure of the hair follicle and the sweat gland, and obtaining the tissue engineering skin with the structure of the hair follicle and the sweat gland after culturing. The skin has elasticity, toughness, vigorous cellular metabolism, strong multiplication capacity, sufficient secretion of extracellular matrices, tight linkage of the cuticular layer, the inophragma and the cells of the dermal layer and little possibility of falling off, enhances the success rate of transplantation, can promote the healing of a wound surface, enhances the effects of restoration and replacement and has the function of regulating the immunological rejection of a receptor; by the contained structure of the hair follicle and the sweat gland, the function of the skin is more complete; the adopted amniotic tissues are postpartum wastes and have extensive source, strong cell multiplication capability and multiplepassage frequency; and the invention is beneficial to the mass production of seed cells and lowers the industrialization cost.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY +1

Vascularized full-thickness tissue-engineered skin layer-by-layer assembled by hydrogel, nanofiber scaffolds and skin cells and preparation method thereof

The invention discloses a vascularized full-thickness tissue-engineered skin layer-by-layer assembled by hydrogel, nanofiber scaffolds and skin cells and a preparation method thereof, and belongs to the technical fields of macromolecule materials and biomedical materials. Artificial tissue engineered skin consists of an epidermal layer and a corium layer, wherein the epidermal layer is formed by alternately stacking nanofiber scaffolds located above the corium layer with seed cells. The corium layer consists of lower-layer nanofiber scaffolds, upper-layer hydrogel scaffolds and three kinds ofseed cells, and the seed cells are distributed on the surface of the nanofiber scaffolds, inside the hydrogel and on the surface of the hydrogel. The vascularized full-thickness tissue-engineered skinis prepared by combination of an electrospinning technology and a macromolecular complexation technology with a fiber / cell layer-gel layer-fiber / cell layer-by-layer self-assembly technology. The artificial tissue-engineered skin with biological function can be used for regeneration and repair of various tissues, especially for wound healing, angiogenesis, scar formation reduction and the like.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Heterogeneous dermis reticular layer stent without basement membrane and cell as well as preparation method thereof

The invention discloses an xenogenic dermal reticular layer scaffold with basilar membrane removal and no cells, which is taken from an dermal reticular layer of a mammal, and has a natural three-dimension structure with larger pores of the dermal reticular layer; the dermal scaffold removes a basilar membrane and has no cells; and the thickness of the dermal scaffold is between 0.2 and 0.8mm. The scaffold is prepared by performing sterile dermis getting, then removing subcutaneous tissue, epidermis, the basilar membrane and a dermal papillary layer, then orderly using distilled water to soak and using trypsinase and an EDTA.Na2 digestive juice to digest, using a phosphate buffer solution to wash after the persistent oscillation, then placing into a Triton X-100 solution for soaking and performing the persistent oscillation, and then using the phosphate buffer solution to wash. The scaffold completely removes the source of a main immunogenic substance in dermis, and reduces the immunogenicity; the scaffold has strong nutrition permeability, quick vascularization speed, high survival rate and good effect when used for the repair of skin wounds, the construction of tissue engineering skin, and tissue filling; and the scaffold has the advantages of rich dermis sources, simple preparation technology, short production period, and low cost.
Owner:THE FIRST AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIVERSITY OF PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products